Registration & Accommodation
Side: Sponsor & Exhibit
Side: General Info
Side: About ICNMD
Side: Past Congresses
The International Society of Nurses in Cancer Care's Conference Management Committee is excited to announce the following speakers for the upcoming International Conference on Cancer Nursing.
Professor Dame Jessica Corner is currently PVC Research and Knowledge Exchange at University of Nottingham. Dame Jessica’s many accolades include: the first nurse at the Institute of Cancer Research to be appointed to Chair, Dame Commander of the British Empire for services to health care research and education and in 2018, when the UK NHS turned 70, she was named as one of the most influential nurses in it’s history.
Nancy Houlihan, MA, RN, AOCN® is the Director of Nursing, Evidence-based Practice at Memorial Sloan Kettering Cancer Center (MSK) in New York and a member of the Executive Nursing Council. She has been an oncology nurse for over thirty years, with expertise in evidence-based management of cancer treatment and disease-related side effects. In her current role she has lead a partnership with the Helene Fuld Health Trust National Institute for Evidence-based Practice in implementation of an extensive program at MSK to ensure the delivery of evidence-based care across the organization. Nancy Houlihan received her Bachelor of Science from Hunter College and her Master of Arts in Nursing from Teachers College, Columbia University, New York and has advanced oncology nursing certification.
She has worked in various clinical, educator and administrative positions including Clinical Nurse Specialist, Clinical Program Manager for the Cancer Survivorship Program and Nurse Leader for the MSK Breast and Imaging Center. She received the MSKCC Rudin Award for Excellence in Advanced Oncology Nursing Practice, the Connie Henke Yarbro Mentorship Award from the Oncology Nursing Foundation, ONS Award for Excellence in Nursing Management and the ONS Lifetime Achievement Award. She has served on the editorial board for Oncology Nursing Forum and Seminars in Oncology Nursing and is President of the Oncology Nursing Society.
Ms. Houlihan has lectured internationally and published about the evidence-based care standards for people with cancer. She has authored articles, abstracts, posters and book chapters about cancer care, symptom management and organizational systems for best practices in care of survivors.
Dr. Theresa M. McDonnell, DNP, ACNP-BC joined Seattle Cancer Care Alliance (SCCA) in 2017 as the Chief Nurse Executive, and Vice President of Clinical Operations and Facilities. She is responsible for the oversight of all PCS Staff, guiding patient care delivery, and ensuring staff accountability for providing a patient-centered clinical practice environment. She was drawn to SCCA for its comprehensive commitment to patient centric care. Seattle Cancer Care Alliance (SCCA) brings together the leading research teams and cancer specialists from Fred Hutch, Seattle Children’s, and UW Medicine - one extraordinary group whose sole purpose is the pursuit of better, longer, richer lives of its patients.
“SCCA desires nothing more (nor less) than to ensure that our talented teams have the information, tools and resources they need to continue to do what is best for our patients.”
Dr. McDonnell came to Seattle from Massachusetts General Hospital (MGH) where she was the Director of Cancer Center Clinical Services. In this role, she was responsible for the daily operations of 22 disease centers made up of 17 multidisciplinary clinics that served nearly 135,000 patients annually. She also co-developed the Financial Care Coordination Team for oncology at MGH, and acted as the Clinical Director for the Katherine A. Gallagher Integrated Therapies Program.
Dr. McDonnell received her Master of Science in Nursing from The MGH Institute of Health Professions (MGHIHP) in 2005, and her Doctorate of Nursing Practice (DNP) from the MGHIHP in 2013. She has served on the board of directors of the Boston Oncology Nursing Society, as a clinical preceptor for Harvard Medical School, as a lecturer at the MGH Institute of Health Professions and as a preceptor for MGH as well as Simmons, Northeastern, Boston College and University of Massachusetts, Academic Clinical Programs.
As a nurse practitioner, Dr. McDonnell’s clinical passion lies in pancreatic cancer. She has received numerous accolades for this expertise including the Schwartz Center Compassionate Caregiver Award in 2009 and the Compassionate Caregiver of the Year Award from the National Pancreas Foundation in November of 2016.
Dr. Tess Huia Moeke-Maxwell, PhD is a Research Fellow for the Te Ārai Palliative and End of Life Care Research Group, School of Nursing, University of Auckland. She currently leads a qualitative study on traditional Māori end-of-life care customs in New Zealand.
Tess was selected as one of New Zealand’s 100 Māori health leaders. Learn more
Richard Sullivan is Professor of Cancer and Global Health at King’s College London, and Director of the King’s Institute of Cancer Policy and co-Director of the Conflict and Health Research Group. His research focuses on global cancer and conflict ecosystems, particularly cancer health systems strengthening. Richard has worked on a number of Lancet and Lancet Oncology commissions, currently the Lancet Commission on Global Diagnostics and the Lancet Oncology European Cancer Research Commission. Richard’s research teams have major programs in capacity building in conflict and health across the Middle East and North Africa, as well as programmes in women’s health and cancer, digital innovation (virtual-reality enhanced surgery) and a wide range of global health security projects. Global cancer research programs cover cancer systems strengthening, affordability, value particularly and political economy, global radiotherapy, social welfare and cancer care in conflict. Richard qualified in medicine and trained in surgery (urology) gaining his PhD in Biochemistry from University College London. Richard has also led research and development programs in the pharmaceutical industry and was Clinical Director of Cancer Research UK between 1999 and 2008.
Keep up to date with Conference News!